1. A single-nucleotide-polymorphism in the 5′-flanking region ofMSX1gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma
    Takahiro Mori et al, 2022, Therapeutic Advances in Medical Oncology CrossRef
  2. Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer


    Linlin Yang et al, 2020, OncoTargets and Therapy CrossRef
  3. Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
    James West et al, 2021, Cells CrossRef
  4. Clinical significance and immune landscape of angiogenesis-related genes in bladder cancer
    Gang Liu et al, 2023, Aging CrossRef
  5. A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy
    Qijie Zhang et al, 2020, Frontiers in Genetics CrossRef
  6. A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation
    Xiao Yang et al, 2021, OncoTargets and Therapy CrossRef
  7. Modeling cartilage pathology in mucopolysaccharidosis VI using iPSCs reveals early dysregulation of chondrogenic and metabolic gene expression
    M. Broeders et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef
  8. MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
    Simon Eppich et al, 2020, International Journal of Molecular Sciences CrossRef
  9. Systematic Investigation of DNA Methylation Associated With Platinum Chemotherapy Resistance Across 13 Cancer Types
    Ruizheng Sun et al, 2021, Frontiers in Pharmacology CrossRef